Our facilities

Through a global GMP manufacturing presence,
ABL supports your projects from Preclinical to Commercial

Rockville, MD
USA

  • PD/QC/Fill
  • Adherent including
  • Fixed bed Bioreactors
  • Suspension 2 x 200L
  • Pre clinical to Phase II

Read More

Lyon,
FRANCE

  • PD/QC
  • Adherent
  • Suspension 3 x 200L
  • Pre clinical to Phase II

Read More

Strasbourg,
FRANCE

  • PD/QC/Fill
  • Adherent
  • Suspension 200/500L
  • Pre clinical to Phase III
  • Commercial readiness program completed in 2022

Read More

In addition to the Strasbourg site, ABL will offer additional large scale commercial capacities for manufacturing of viral vectors in 2024